How much Erlotinib for EGFR Mutation Cancer?

Erlotinib is a type of cancer drug that targets a specific part of the EGFR in people with NSCLC or pancreatic cancer and has EGFR mutations. It works by stopping signals from the EGFR. There are three doses of the medicine: 25, 100, and 150 milligrams, and they all come in a coated tablet form.

The go-to dose for treating cancer is 150 milligrams, and it’s usually taken by itself with nothing in your stomach. The medicine comes in bottles with 30 tablets inside.